Will Medicare Cover the Controversial Alzheimer’s Drug?
By Dennis Thompson HealthDay Reporter FRIDAY, Jan. 7, 2022 (HealthDay News) Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. Centers for […]
Read More